Glenmark Pharmaceuticals Ltd.
|
HALFYEARLY RESULTS
|
|
You can view the
Halfyearly Results
for the last 5 years.
Market Cap. (Rs.)
|
29416.70 Cr.
|
P/BV
|
3.11
|
Book Value (Rs.)
|
335.73
|
52 Week High/Low (Rs.)
|
1098/581
|
FV/ML
|
1/1
|
P/E(X)
|
98.97
|
Bookclosure
|
29/09/2023
|
EPS (Rs.)
|
10.53
|
Div Yield (%)
|
0.24
|
|
(Rs. in Crs.)
Net Sales/Income from operations | 6243.44 | 6764.47 | 6032.58 | 6102.62 | 6112.34 |
Other Operating Income | 0.00 | 73.10 | 119.96 | 89.94 | 0.00 |
Total Income From Operations | 6243.44 | 6837.57 | 6152.54 | 6192.56 | 6112.34 |
| | | | | |
EXPENDITURE | | | | | |
Consumption of Raw Materials | 1746.01 | 1750.98 | 1842.81 | 1510.14 | 1768.62 |
Purchase of Traded Goods | 827.26 | 684.70 | 583.56 | 512.80 | 604.86 |
Increase/Decrease in Stocks | -187.69 | -77.50 | -247.59 | 79.82 | -90.96 |
Employees Cost | 1414.15 | 1413.58 | 1367.38 | 1163.67 | 1283.75 |
Depreciation | 283.49 | 308.81 | 302.46 | 250.45 | 236.26 |
Other Expenses | 1544.07 | 1840.61 | 1553.22 | 1769.58 | 1382.32 |
Total Expenses | 5627.30 | 5921.17 | 5401.84 | 5286.46 | 5184.86 |
| | | | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 616.14 | 916.40 | 750.70 | 906.10 | 927.49 |
Other Income | 21.42 | 36.20 | 280.58 | 121.10 | 45.58 |
P/L Before Interest, Excpt. Items & Tax | 637.56 | 952.60 | 1031.28 | 1027.20 | 973.06 |
Interest | 233.07 | 206.52 | 143.06 | 153.55 | 144.55 |
P/L Before Exceptional Items & Tax | 404.50 | 746.08 | 888.22 | 873.65 | 828.51 |
Exceptional Items | -377.45 | -765.85 | 0.00 | -260.91 | 0.00 |
P/L Before Tax | 27.05 | -19.77 | 888.22 | 612.74 | 828.51 |
Tax | 169.67 | 92.60 | 398.45 | 200.42 | 247.18 |
P/L After Tax from Ordinary Activities | -142.62 | -112.38 | 489.78 | 412.32 | 581.33 |
Extra Ordinary Item | 254.19 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit/Loss For the Period | 111.57 | -112.38 | 489.78 | 412.32 | 581.33 |
Minority Interest | -43.58 | -25.17 | -36.81 | -34.83 | 0.00 |
Net P/L After Minority Interest & Share Of Associates | 67.99 | -428.30 | 452.97 | 377.49 | 581.33 |
| | | | | |
Equity Share Capital | 28.22 | 28.22 | 28.22 | 28.22 | 28.22 |
EPS Before Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 2.41 | -3.98 | 16.05 | 14.61 | 20.60 |
Diluted EPS (Rs.) | 2.41 | (3.98) | 16.05 | 14.61 | 20.60 |
EPS After Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 2.41 | -3.98 | 16.05 | 14.61 | 20.60 |
Diluted EPS (Rs.) | 2.41 | 0.00 | 16.05 | 0.00 | 20.60 |
| | | | | |
PBITOE Margin (%) | 9.86 | 13.40 | 12.20 | 14.63 | 15.17 |
PBTE Margin (%) | 6.47 | 10.91 | 14.43 | 14.10 | 13.55 |
PBT Margin (%) | 0.43 | -0.28 | 14.43 | 9.89 | 13.55 |
PAT Margin (%) | 1.78 | -1.64 | 7.96 | 6.65 | 9.51 |
PAT After MI And SOA Margin (%) | 1.08 | -6.26 | 7.36 | 6.09 | 9.51 |